NorthWest Biotherapeutics Inc (NWBO)

[CrashOverride]

We cannot advertise DCVax as it does not have marketing approval. Adam Feuerstein likely filed a complaint against us with MHRA due to the Sawston article published after we got MIA license. The last time WPRI covered the Landmark Trial Results our wonderful researchers Dr Steven Toms mentioned that Northwest Biotherapeutics are seeking approval.

Dr Toms said we could see action from the FDA this year. He does not know but he rightly pointed out the unprecedented results for the orphan disease, Glioblastoma, as did Dr Heinrich Elinzano. I suspect we will hear a summary of the results as well as an update on regulatory status. If we don't hear an update on regulatory affairs then perhaps we will have patient testimonial. Either way coverage including Ivy League researchers only benefits our company as they are the salespeople for DCVax.

I remember many who were quite despondent after NYAS as we all waited for JAMA. Too many thought we were rejected from publication. This world-class management team got it done. Let's give them more time but I think it won't be much longer considering the application has been completed. Buy now or cry later!